Serena Barozzi

Medicine & Life Sciences

1. Thrombocytopenia 100%
2. MYH9-Related Disorders 66%
3. Mutation 58%
4. Blood Platelets 50%
5. Megakaryocytes 38%
6. Myosin Heavy Chains 34%
7. Thrombocytopenia chromosome breakage 33%
8. Cytoplasmic Structures 32%
9. Congenital amegakaryocytic thrombocytopenia 27%
10. Loss of Function Mutation 24%
11. Thrombopoietin 23%
12. eltrombopag 21%
13. Myelodysplastic Syndromes 17%
14. Thrombopoietin Receptors 17%
15. Nonmuscle Myosin Type IIA 15%
16. Proteasome Endopeptidase Complex 15%
17. Hemorrhage 15%
18. Ubiquitin 14%
19. Deafness 14%
20. Bone Marrow 14%
21. Genes 14%
22. Precursor Cell Lymphoblastic Leukemia-Lymphoma 14%
23. Diagnostic Errors 14%
24. Cataract 13%
25. 5' Untranslated Regions 10%
26. Dysphonia 9%
27. Platelet Count 9%
28. Kinesin 9%
29. Coronavirus 9%
30. Genetic Association Studies 9%
31. Phase II Clinical Trials 8%
32. Desmin 8%
33. Tinnitus 8%
34. Pandemics 7%
35. Hematuria 7%
36. Pedigree 7%
37. romiplostim 7%
38. Muscle Cells 6%
39. Voice Disorders 6%
40. CDC2 Protein Kinase 6%
41. Proteins 6%
42. Color 5%
43. Mitochondria 5%
44. Cell Movement 5%
45. Cell Differentiation 5%
46. convulxin 5%
47. Skeletal Muscle 5%
48. Bone Marrow Failure Disorders 5%
49. Therapeutics 5%
50. Cell Death 5%